Gain Therapeutics Inc (GANX)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Assets | 28.33M | 24.1M | 21.32M | 18.26M | 14.1M | 18.61M | 14.58M | 19.2M |
Total Current Assets | 24.35M | 21.09M | 19.32M | 17.31M | 13.24M | 17.78M | 13.86M | 18.54M |
Cash and Equivalents | 10.88M | 7.28M | 5.99M | 6.32M | 4.27M | 11.8M | 10.64M | 16.94M |
Total Non-Current Assets | 4.11M | 3.15M | 2.15M | 1.09M | 982k | 956k | 827k | 780k |
Total Liabilities | 5.66M | 5.22M | 6.18M | 7.17M | 6.77M | 6.03M | 5.94M | 7.41M |
Total Current Liabilities | 4.33M | 4.13M | 5.16M | 5.59M | 5.76M | 4.95M | 5M | 6.52M |
Total Non-Current Liabilities | 1.82M | 1.59M | 1.51M | 2.05M | 1.44M | 1.53M | 1.33M | 1.26M |
Common Equity | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 2k | 2k | 3k |
Retained Earnings | -20.93M | -20.93M | -38.52M | -38.52M | -38.52M | -38.52M | -60.78M | -60.78M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 660k | 9.6M | 38.99M | 24.1M | 18.61M |
Total Current Assets | 430k | 8.99M | 37.72M | 21.09M | 17.78M |
Cash and Equivalents | 303k | 7.49M | 36.88M | 7.28M | 11.8M |
Total Non-Current Assets | -450k | 6.2M | 34.82M | 18.88M | 12.58M |
Total Liabilities | 1.11M | 3.4M | 4.17M | 5.22M | 6.03M |
Total Current Liabilities | 879k | 2.12M | 2.55M | 4.13M | 4.95M |
Total Non-Current Liabilities | 231k | 2M | 2.21M | 1.59M | 1.53M |
Total Equity | -450k | 6.2M | 34.82M | 18.88M | 12.58M |
Common Equity | 0 | 1,000 | 1,000 | 1,000 | 2k |
Retained Earnings | -1.26M | -3.46M | -7.04M | -20.93M | -38.52M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.